Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System

NCT: NCT04195568 · ACTIVE_NOT_RECRUITING

NCT IDNCT04195568
StatusACTIVE_NOT_RECRUITING
Start Date2020-07-07
Completion2028-09-13
SponsorStryker Neurovascular (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this study is to evaluate the safety and effectiveness of the Surpass™ Evolve Flow Diverter System in the treatment of unruptured, wide-neck intracranial aneurysms measuring ≤ 12 mm and located on the ICA or its branches

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑